Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
about
New β-Lactamase Inhibitors in the ClinicPseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.Overcoming β-lactam resistance in Gram-negative pathogens.What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.In Vitro Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa.Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.The Versatile Mutational Resistome of Pseudomonas aeruginosa.Failure of ceftolozane‐tazobactam salvage therapy in complicated pneumonia with lung abscess.Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014-2015Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa
P2860
Q26747150-346D178B-790E-44C8-B5AC-A1FADFB56C98Q37643058-87E679ED-8DD8-4141-B150-6B66D811DDF2Q38741337-C2672682-4796-4A47-B802-DF9B4F539336Q38777049-3428AE2E-E825-4A43-A569-B0C9E3CE4F3AQ38856197-0F9CC9CC-63E2-4501-B0F2-4D22AAA93262Q38862139-2671ED65-0B24-442D-B4C6-76E136BAF29DQ39120027-8E438A4D-7CA7-4E50-8B2C-74445B753E17Q40056971-B6E743FD-9237-49CD-9DA3-4ECE35C5A402Q40148490-8C821CC3-9FFD-426E-83EC-2E7B8D85FCB8Q40296000-640E6742-A5A2-42C5-83FB-512A3D7BE2A1Q45897898-7C830AAA-250A-418A-A35A-05ECC36888C8Q46286684-10E66377-976D-41BD-B92B-8EB2A5B8FC77Q47218700-45DBE99D-57C6-4AD9-846D-828862F96B1EQ47748447-516ABE78-F206-4493-AC1C-1BA723ED5838Q47769606-A6F3B2B0-9808-4E63-9C25-EACFCA93FAE4Q49921578-874E7BDF-EB0F-49B1-8931-2981A79C2A6AQ52313185-709C409A-CBBB-476B-98A5-E063CB5C5BE1Q55456610-F885F338-7564-4077-8526-EBF054CB1822Q56835140-D2F70C68-D07B-49F8-819B-19C44DCCA826Q59126430-B1075266-37AF-4DD2-8789-54689B2BFCD8
P2860
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mutations in β-Lactamase AmpC ...... ntipseudomonal Cephalosporins.
@ast
Mutations in β-Lactamase AmpC ...... ntipseudomonal Cephalosporins.
@en
type
label
Mutations in β-Lactamase AmpC ...... ntipseudomonal Cephalosporins.
@ast
Mutations in β-Lactamase AmpC ...... ntipseudomonal Cephalosporins.
@en
prefLabel
Mutations in β-Lactamase AmpC ...... ntipseudomonal Cephalosporins.
@ast
Mutations in β-Lactamase AmpC ...... ntipseudomonal Cephalosporins.
@en
P2093
P2860
P356
P1476
Mutations in β-Lactamase AmpC ...... Antipseudomonal Cephalosporins
@en
P2093
D Fournier
M Berrazeg
S Loeffert
Véronique Yvette Ntsogo Enguéné
P2860
P304
P356
10.1128/AAC.00825-15
P407
P50
P577
2015-07-27T00:00:00Z